Secukinumab for PASS syndrome: A new choice for therapeutic challenge?
Year: 2022
Type: article
Study design: Case Report
Source: Dermatologic Therapy
DOI: 10.1111/dth.15507
Authors: Mengmeng Li, Hongmei Xiang, Yuxiang Liang, Li Xue, Xingli Zhou, Lirong Yang, Hongjie Liu, Min Yang, Jing Tang, Wei Li
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4223975829